#140 - Gerald Shulman, M.D., Ph.D.: A masterclass on insulin resistance—molecular mechanisms and clinical implications

Dec 7, 2020 Episode Page ↗
Overview

Dr. Gerald Shulman, Professor of Medicine at Yale, clarifies insulin resistance as a root cause of chronic disease, detailing its mechanisms in muscle and liver. He discusses how diet, exercise, and pharmacological agents like Metformin impact it, and its evolutionary significance.

At a Glance
11 Insights
2h 8m Duration
13 Topics
7 Concepts

Deep Dive Analysis

Dr. Shulman's Background and Interest in Metabolism

Insulin Resistance as a Root Cause of Chronic Disease

Using NMR Spectroscopy to Study Cellular Metabolism

Defining and Diagnosing Insulin Resistance

The Role of Lipids in Muscle Insulin Resistance

Molecular Mechanism of Muscle Glucose Transport Block

Exercise Reverses Muscle Insulin Resistance and Fatty Liver

Molecular Basis of Liver Insulin Resistance

Evolutionary Explanation for Insulin Resistance

Insulin's Regulation of Gluconeogenesis and its Dysregulation

Role of Inflammation and Fat in Diabetes Progression

Therapeutic Approaches for Fatty Liver and Insulin Resistance

Metformin's Mechanism of Action and Longevity Implications

Insulin Resistance

A condition where the same amount of insulin is less effective at causing muscle to take up glucose, the liver to turn off glucose production, or fat cells to stop fat breakdown. This requires the body to produce more insulin to achieve the same metabolic effects.

Metabolic Flux

In metabolism, flux refers to the dynamic rate at which metabolites like glucose or fatty acids are produced, consumed, and moved through various pathways within cells and tissues. It is considered more informative than just measuring static concentrations of metabolites.

NMR Spectroscopy

Nuclear Magnetic Resonance spectroscopy is a non-invasive technique that utilizes the magnetic properties of atomic nuclei (e.g., C13, P31, H1) to measure the amount and chemical environment of specific metabolites inside living cells, allowing researchers to track metabolic pathways and their rates in real-time.

Diacylglycerol (DAG)

A lipid metabolite consisting of a glycerol backbone with two fatty acids. DAGs are bioactive molecules that, when accumulated in excess inside cells, activate novel protein kinase Cs (PKCs), which interfere with insulin signaling and contribute to insulin resistance.

Gluconeogenesis

The metabolic pathway by which the liver synthesizes glucose from non-carbohydrate precursors, such as amino acids (e.g., alanine) and lactate. This process is critical for maintaining blood glucose levels during fasting and for supplying glucose to the brain.

Lipodystrophy

A rare condition characterized by a lack of adipose tissue (fat cells), either generalized or localized. Patients with lipodystrophy often develop severe insulin resistance, fatty liver, and diabetes, highlighting the importance of proper fat storage for metabolic health.

Mitochondrial Uncoupling

A process where the efficiency of mitochondria in producing ATP is deliberately reduced, causing them to burn more fuel (like fat) to generate the same amount of ATP, with the excess energy dissipated as heat. This can be therapeutically targeted to reduce ectopic fat accumulation in organs like the liver.

?
What is the most important pathological condition in our species?

Insulin resistance is argued to be the most important pathological condition, forming the foundation upon which major chronic diseases like atherosclerosis, cancer, and dementia are amplified.

?
How does Dr. Shulman's NMR technique differ from standard blood tests?

While blood tests provide a static snapshot of metabolite concentrations, NMR techniques allow scientists to observe the dynamic 'flux' or movement of glucose and fat inside human cells, providing a 'video' rather than a 'picture' of metabolism.

?
What is the primary fate of ingested carbohydrates in a healthy individual?

In a healthy individual, 80-90% of ingested carbohydrates are stored as glycogen in the liver and muscle.

?
What is the initial defect in muscle insulin resistance, and where does it occur?

The initial defect in muscle insulin resistance is a block in glucose transport into the muscle cell, specifically at the GLUT4 transporter, which is impaired from translocating to the cell membrane.

?
What is the molecular mechanism behind lipid-induced muscle insulin resistance?

An imbalance between fatty acid uptake, mitochondrial oxidation, and triglyceride storage leads to the accumulation of diacylglycerol (DAG), which activates novel protein kinase Cs (PKC theta and epsilon), inhibiting insulin signaling and GLUT4 translocation.

?
How does exercise help reverse muscle insulin resistance?

Exercise activates AMPK, which can cause GLUT4 translocation to the cell membrane independently of the impaired insulin signaling pathway, effectively bypassing the block in glucose uptake. Chronic exercise may also reduce intracellular lipids like DAGs.

?
What is the order of progression of insulin resistance in humans versus rodents?

In humans, muscle insulin resistance typically precedes liver insulin resistance, whereas in rodents, liver fat and insulin resistance often develop first.

?
What is the evolutionary reason for insulin resistance?

Insulin resistance likely evolved as a protective mechanism to ensure survival during starvation, by preserving circulating glucose for the brain's critical energy needs by limiting its uptake into other tissues like muscle and liver.

?
What is the primary mechanism by which insulin regulates gluconeogenesis in the liver?

Insulin primarily regulates gluconeogenesis indirectly by putting the brakes on peripheral lipolysis, which reduces fatty acid delivery to the liver, thereby decreasing acetyl-CoA generation and pyruvate carboxylase activity.

?
What is the role of inflammation in the progression to type 2 diabetes?

Localized inflammation in fat cells (releasing TNF-Alpha, IL-6) promotes increased lipolysis, leading to more fatty acid delivery to the liver, elevated acetyl-CoA, and accelerated gluconeogenesis, which drives fasting hyperglycemia in type 2 diabetes.

?
What is the most impactful organ to target for pharmacological treatment of metabolic disease?

The liver is considered the most impactful organ to target pharmacologically for metabolic disease, as it is central to lipidemia, hyperlipidemia, and diabetes.

?
What is the proposed mechanism of action for Metformin at clinically relevant concentrations?

At clinically relevant concentrations (50-100 micromolar), Metformin is believed to inhibit mitochondrial glycerol 3-phosphate dehydrogenase, which leads to an increase in cytosolic NADH/NAD ratio, inhibiting gluconeogenesis specifically from lactate and glycerol.

1. Prioritize Metabolic Health

To delay the onset of death and chronic disease, it is essential to prioritize and fix one’s metabolism.

2. Embrace Diet and Exercise

Diet and exercise are the most effective strategies to address and reverse metabolic issues and improve overall health.

3. Find Sustainable Weight Loss

Identify a weight loss strategy that works for you and that you can adhere to long-term, as sustained adherence is crucial for lasting results beyond initial weight loss.

4. Reverse Muscle Insulin Resistance with Exercise

Engage in regular exercise, such as three 15-minute bouts on a StairMaster at 65% MVO2 max for six weeks, to normalize insulin-stimulated muscle glycogen synthesis and reverse insulin resistance.

5. Acute Exercise Reduces Liver Fat

A single 45-minute bout of exercise can lead to increased glucose deposition as muscle glycogen, significant reductions in de novo lipogenesis, and lower liver triglycerides.

6. Exercise for Type 1 Diabetes

Patients with Type 1 diabetes engaging in modest intensity aerobic exercise (e.g., brisk walking for 1-2 hours daily) can achieve reasonable glycemic control with significantly reduced insulin requirements, especially when restricting carbohydrates.

7. Understand Insulin Resistance

To truly understand longevity, it is crucial to comprehend the meaning and implications of insulin resistance.

8. Prioritize Subcutaneous Fat Storage

If fat must be stored, it is metabolically healthier to store it subcutaneously rather than inside liver and muscle cells.

9. Monitor Triglyceride Levels

Consider triglyceride levels above 100 mg/dL as abnormal and a red flag, especially if they are more than twice your HDL cholesterol.

10. Assess Insulin Sensitivity

To understand your metabolic health, consider getting tested for insulin sensitivity, which can reveal insulin resistance even in lean, young individuals.

11. Re-listen to Complex Content

When encountering technical or complex information, re-listening to the content can significantly aid in retention and deeper understanding.

Insulin resistance is driving a lot of disease. And you're also spot on in that that's what's killing our patients with type 2 diabetes. It is heart disease.

Gerald Shulman

What we know is what's much more important than just measuring concentration is flux.

Gerald Shulman

If you really want to understand longevity, you're going to have to sort of figure out what insulin resistance means.

Peter Attia

The real culprit, and we've been able to just quickly really test this rigorously, gene knockout... is diacylglycerol.

Gerald Shulman

Insulin resistance was a protective mechanism throughout evolution that allowed us to survive all species during starvation.

Gerald Shulman

If I had to pick two molecules that are driving metabolic disease, it's acetyl-CoA driving perfect carboxylase. And again, the diacylglycerol is activating epsilon.

Gerald Shulman

Whatever works for you to lose weight, because I know if you lose the weight, your diabetes is going to get better.

Gerald Shulman

Reversing Type 2 Diabetes through Hypocaloric Feeding

Gerald Shulman
  1. Consume a short-term hypocaloric diet of 1200 calories per day.
  2. This approach leads to a reduction in ectopic lipid accumulation.
  3. This process can reverse all associated abnormalities and type 2 diabetes.

Exercise Protocol to Reverse Muscle Insulin Resistance

Gerald Shulman
  1. Engage in StairMaster exercise for six weeks.
  2. Perform three 15-minute bouts per session.
  3. Maintain exercise intensity at approximately 65% of maximum oxygen consumption (MVO2 max).
25-50%
Prevalence of insulin resistance in the population Approximately one quarter to one half of the US population, often asymptomatic.
50%
Reduction in muscle glycogen synthesis in insulin-resistant individuals Compared to insulin-sensitive individuals, due to a block in glucose transport.
2-fold (up to 1.5 millimolar)
Increase in plasma fatty acids to induce insulin resistance Achieved by intralipid infusion for 3-4 hours in healthy individuals, making them as insulin resistant as those with type 2 diabetes.
2-3 times higher
Insulin concentrations in insulin-resistant individuals (post-meal) Compared to insulin-sensitive individuals, required to maintain euglycemia.
3 times higher
Portal vein insulin levels seen by the liver Compared to peripheral plasma insulin levels in insulin-resistant individuals.
2.3-fold
Increase in liver triglyceride in insulin-resistant individuals Observed in young, lean, insulin-resistant individuals after consuming two high-carbohydrate meals.
Greater than 2-fold
Increase in de novo lipogenesis in insulin-resistant individuals Observed in young, lean, insulin-resistant individuals after consuming two high-carbohydrate meals.
80%
Increase in plasma triglycerides in insulin-resistant individuals From approximately 60 mg/dL to 100-105 mg/dL in euglycemic insulin-resistant individuals, compared to insulin-sensitive counterparts.
Approximately 2 days
Time to deplete liver glycogen in humans during starvation Unlike mice, which deplete liver glycogen much faster (e.g., overnight).
30-50 micromolar
Clinically relevant plasma concentrations of Metformin In patients taking 1 gram twice daily.
Up to 100 micromolar
Portal vein concentrations of Metformin Estimated to be 2-3 times higher than plasma levels.
Millimolar concentrations
Concentration of Metformin required to inhibit Complex I Approximately 10-fold higher than clinically relevant concentrations, suggesting Complex I inhibition is not the primary mechanism of action in humans.